Rznomics

476830· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩21,600+1.41%

2026-11-02

Financials

Valuation Metrics

Rznomics's Market Cap is ₩6088B. At end of 2025 it was ₩2.3T. Ranked #391 of 2,410 in KR market (top 16%), #132 of 1,631 on KOSDAQ (top 8%), #41 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 18%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	608.78B KRW	KR#391/2,410 Sec#41/231
Revenue	2.00B KRW	KR#2,372/2,410 Sec#215/231
Net Income	-27.61B KRW	KR—/2,410 Sec—/231
Total Assets	51.56B KRW	KR#2,190/2,410 Sec#197/231
Net Assets	46.61B KRW	KR#1,952/2,410 Sec#165/231
Value
P/B	13.06x	KR#2,382/2,410 Sec#219/231
P/S	303.82x	KR#2,395/2,410 Sec#221/231
FCF Yield	-1.79%	KR—/2,410 Sec—/231
Profitability
ROE	-59.24%	KR#2,288/2,410 Sec#203/231
ROA	-53.55%	KR#2,359/2,410 Sec#217/231
Op. Margin	-1418.93%	KR#2,373/2,410 Sec#218/231
Financial Health
Debt Ratio	10.62%	KR#158/2,410 Sec#32/231
FCF	-10.90B KRW	KR#1,726/2,410 Sec#153/231
Cash	6.85B KRW	KR#1,886/2,410 Sec#170/231
Current Ratio	9.68x	KR#103/2,410 Sec#23/231
Performance
1M Return	-23.27%	KR#1,372/2,410 Sec#139/231
From 52W High	-82.39%	KR#2,335/2,410 Sec#217/231
1Y MDD	-82.58%	KR#2,321/2,410 Sec#214/231
Trading
Volume	90,353 shares	KR#321/2,410 Sec#31/231
Trading Value	1.94B KRW	KR#290/2,410 Sec#25/231
Foreign Own.	9.29%	KR#503/2,410 Sec#42/231
Per Share
EPS	-980 KRW	KR—/2,410 Sec—/231
BPS	1,654 KRW	KR#2,155/2,410 Sec#182/231